![]() ![]() The therapeutic benefit of hyaluronidase may be reduced by corticosteroids. Risk Factor D (Consider therapy modification) In particular, recent or ongoing corticosteroid medication may reduce the plasma ACTH response to corticorelin. The therapeutic benefit of corticorelin may be reduced by corticosteroids. Particularly, there may be a higher risk of GI bleeding or ulcers.Ĭorticosteroids may intensify Ritodrine's harmful or hazardous effects.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |